Seratrodast - CAS 112665-43-7

Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.

Reactive Oxygen Species, Ferroptosis, JNK, MDM-2/p53, COX, Prostaglandin Receptor, ROS, PPAR

GPCR/G Protein, NF-κB, Neuroscience, MAPK, Metabolism, DNA Damage/DNA Repair, Immunology/Inflammation, Apoptosis

112615

0.9969

C22H26O4

354.44

C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2

-20°C

Ice Packs

Small Compound